Editorial Board Members

Editor-in-Chief

Seenivasagam SR, Drug Discovery, Kanyakumari District, India

Senior Managing Editors

K.H. Pearce, GlaxoSmithKline, NC, USA
V. Shanmugasundaram, Pfizer PharmaTherapeutics Research & Development, Groton, CT, USA
Ross Breckenridge, Professor in Clinical Pharmacology University college of London, UK
Bello, Shaibu Oricha, Department of Pharmacology, College of Health Sciences Usmanu Danfodiyo University Sokoto, Nigeria
L.K. Minor, Johnson & Johnson Pharmaceutical R & D, Spring House, PA, USA
K. Mueller, Hoffman-La Roche Ltd, Basel, Switzerland

Associate Editors

Martin Braddock, AstraZeneca Research and Development, Leicestershire, UK
Detlev Boison, RS Dow Neurobiology Laboratories, Portland
A.M. Aronov, Vertex Pharmaceuticals, Inc, Cambridge, MA, USA
K. Islam, Arpida Ltd, Muenchenstein, Switzerland
T. Ochiya, National Cancer Center Research Institute, Tokyo, Japan
G. Subramanian, Sanofi-aventis, Bridgewater, NJ, USA
G. Trainor, Bristol-Myers Squibb Pharmaceutical, Delaware, NJ, USA

Editorial Board

Reem Smoum Jaouni, The Institute of Drug Research (IDR), School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem Ein Kerem campus, Jerusalem
T.L. Dunckley, Translational Genomics Research Institute, Phoenix, AZ, USA
C.P. Hart, Threshold Pharmaceuticals, Redwood City, CA, USA
I.V. Tetko, Institute for Bioinformatics, Neuherberg, Germany
YiYun Cheng, University of Science and Technology of China, China
Yong Qian, Centers for Disease Control and Prevention, USA
Yili Ding, Drug Discovery, Valeant Pharmaceuticals Research & Development, USA
Davide Gianni, Innovative Medicines and Early Development, Discovery Sciences - Cellular Assay Development, Astrazeneca, United Kingdom
Chukwuebuka Egbuna, New Divine Favour Pharmaceutical, Akuzor, NKPOR, Anambra State, Nigeria
Peter T.-H. Wong, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Nobuyuki Kuramoto, Associate Professor Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Japan
Natassa Pippa, Department of Pharmaceutical Technology, National and Kapodistrian University of Athens, Greece
Sinerik Ayrapetyan, Head Research Council, UNESCO Chair-Life Sciences International Postgraduate Educational Center, Yerevan, Armenia
Flávia Cristina Moreira de Sousa, Department of Fonseca Pharmacy, University of Porto, Portugal
Palanisamy sankar, Assistant Professor, Department of Pharmacology and Toxicology, Veterinary College and Research Institute, India
Ali Seyfoddin, Department of Drug Delivery and Pharmacology, Auckland University of Technology, New zeland
Rodney Siwale, Western New England University College of Pharmacy, USA
Rhishikesh Mandke, Polygen Pharmaceuticals, LLC, USA
Hibreniguss Terefe, ExxPharma LLC, USA
Jamie Tsung, Momenta Pharmaceuticals, USA
Xueming Wu, Par Pharmaceutical, USA
Gael Hédou, Neurosciences Centre of Excellence for Drug Discovery, United Kingdom
Paul Andrews, Stem Cell Solutions Ltd, Scotland
Jan Eickhoff, Head of Assay Development and Screening, Hit Discovery Constance GmbH, Managing Director, Germany
Jurriaan Zwier, Research Scientist, Cisbio Bioassays, France
Tiziana Adage, BIT Pharma GmbH, Austria
Calvin Yu-Chian Chen, Laboratory of Computational and Systems Biology, School of Chinese Medicine, China Medical University, Taiwan
Busi Siddhardha, Centre for Microbiology, School of Life Sciences, Pondicherry University, India
Wandee Gritsanapan, Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
James M. Mbaria, Department of public Health, Pharmacology & Toxicology, University of Nairobi, Kenya